Search Results - "Batchelor, J.M."

Refine Results
  1. 1

    Validation of the Vitiligo Noticeability Scale: a patient-reported outcome measure of vitiligo treatment success by Batchelor, J.M., Tan, W., Tour, S., Yong, A., Montgomery, A.A., Thomas, K.S.

    Published in British journal of dermatology (1951) (01-02-2016)
    “…Summary Background Patient‐reported outcome measures are rarely used in vitiligo trials. The Vitiligo Noticeability Scale (VNS) is a new patient‐reported…”
    Get full text
    Journal Article
  2. 2

    Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials by Eleftheriadou, V., Thomas, K.S., Whitton, M.E., Batchelor, J.M., Ravenscroft, J.C.

    Published in British journal of dermatology (1951) (01-10-2012)
    “…Summary Background  Relevant and reliable outcomes play a crucial role in the correct interpretation and comparison of the results of clinical trials. There is…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta‐analysis by Osinubi, O., Grainge, M.J., Hong, L., Ahmed, A., Batchelor, J.M., Grindlay, D., Thompson, A.R., Ratib, S.

    Published in British journal of dermatology (1951) (01-04-2018)
    “…Summary Background Vitiligo is a chronic disorder causing skin depigmentation with global prevalence varying from 0·2% to 1·8%. U.K. guidelines recommend…”
    Get full text
    Journal Article
  7. 7

    Evidence-based management of vitiligo: summary of a Cochrane systematic review by Whitton, M., Pinart, M., Batchelor, J.M., Leonardi-Bee, J., Gonzalez, U., Jiyad, Z., Eleftheriadou, V., Ezzedine, K.

    Published in British journal of dermatology (1951) (01-05-2016)
    “…Summary Vitiligo affects around 1% of the world's population. Despite it being relatively common, there is still no effective treatment. The objective of this…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta‐analysis by Osinubi, O., Grainge, M.J., Hong, L., Ahmed, A., Batchelor, J.M., Grindlay, D., Thompson, A.R., Ratib, S.

    Published in British journal of dermatology (1951) (01-04-2018)
    “…Summary Vitiligo is a long‐term condition where pale white patches develop on the skin. It's caused by a lack of melanin, a pigment (colour) in the skin…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20